Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 116 followers
Latest posts
Last updated about 23 hours ago
PDCO minutes of the 24-27 March 2026 meeting
about 23 hours ago
PDCO minutes of the 24-27 March 2026 meeting
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 20-23 April 2026
about 24 hours ago
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting...
List of medicines currently in PRIME scheme
about 24 hours ago
List of medicines currently in PRIME scheme
Human medicines European public assessment report (EPAR): Olanzapine Glenmark Europe, olanzapine, Date of authorisation: 03/12/2009, Revision: 15, Status: Authorised
about 24 hours ago
Human medicines European public assessment report (EPAR): Olanzapine Glenmark Europe, olanzapine, Date...
Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Date of authorisation: 03/12/2009, Revision: 16, Status: Authorised
about 24 hours ago
Human medicines European public assessment report (EPAR): Olanzapine Glenmark, olanzapine, Date of...
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 14, Status: Authorised
about 24 hours ago
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date...
Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 13, Status: Authorised
about 24 hours ago
Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date...
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 73, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation...
Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated) Takeda, Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 3,
1 day ago
Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated)...
Human medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation: 02/09/1999, Revision: 44, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation...